每经头条（nbdtoutiao）——5年增长33倍，这类新险种卖爆了，身边很多人都需要，30多家险企蜂拥而 入⋯⋯ （记者 王晓波） 每经AI快讯，民生健康（SZ 301507，收盘价：13.67元）9月26日晚间发布公告称，截至2025年9月25 日，公司通过回购专用证券账户，以集中竞价交易方式已累计回购股份约134万股，占公司当前总股本 的0.38%，最高成交价为14.03元/股，最低成交价为11.83元/股，支付金额约为1750万元。 2025年1至6月份，民生健康的营业收入构成为：维生素与矿物质补充剂系列占比92.15%，其他业务占 比7.85%。 截至发稿，民生健康市值为49亿元。 ...

Group 1 - The core point of the article is that Minsheng Health (SZ 301507) announced the results of its board meeting held on August 22, 2025, where the 2025 semi-annual report and its summary were reviewed [1] - For the first half of 2025, Minsheng Health's revenue composition shows that vitamin and mineral supplements accounted for 92.15% of total revenue, while other businesses contributed 7.85% [1] - As of the time of reporting, Minsheng Health has a market capitalization of 5.5 billion yuan [1] Group 2 - The article also mentions a separate initiative where a veterinary medicine PhD is cultivating crops on 25,000 acres in Africa, achieving a yield of 250 jin per acre in the first season, with plans to expand to 100,000 acres [1] - The initiative is looking to hire individuals with a monthly salary ranging from 10,000 to 20,000 yuan [1]

Group 1 - Minsheng Health (SZ 301507, closing price: 15.52 CNY) announced on August 19 that its subsidiary, Minsheng Zhongke Jiayi (Shandong) Bioengineering Co., Ltd., received an invention patent certificate from the National Intellectual Property Administration for a strain of Lactobacillus curvatus JYLU-88 that promotes EGF and EGFR expression [2] - For the fiscal year 2024, Minsheng Health's revenue composition is as follows: vitamin and mineral supplements account for 96.91%, other health products for 1.93%, probiotics for 0.66%, other businesses for 0.39%, and therapeutic drugs for 0.11% [2]

Core Viewpoint - Minsheng Health announced a share buyback plan, having repurchased approximately 1.33 million shares, representing 0.37% of the total share capital, with a total expenditure of around 17.26 million yuan [2] Summary by Category Share Buyback - As of July 31, 2025, Minsheng Health has repurchased about 1.33 million shares through a special securities account via centralized bidding, with a maximum transaction price of 13.82 yuan per share and a minimum transaction price of 11.83 yuan per share [2] Revenue Composition - For the year 2024, the revenue composition of Minsheng Health is as follows: - Vitamin and mineral supplements account for 96.91% - Other health products account for 1.93% - Probiotics account for 0.66% - Other businesses account for 0.39% - Therapeutic drugs account for 0.11% [2]